TheCenters for Disease Control and Prevention (CDC) reports this week's national respiratory virus data is low.COVID-19, Flu, ...

Vaxxas, has announced the company has been granted a licence to develop a next-generation vaccine antigen (DS2).

Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, today announced that the United States National Institutes of ...

Nov. 7—(StatePoint) Each year, as many as 80,000 children younger than 5 are hospitalized due to respiratory syncytial virus (RSV) in the United States. RSV is the leading cause of hospitalization in ...

ATLANTA — A Loganville family is urging caution after their 3-week-old daughter was hospitalized with respiratory syncytial virus (RSV), a respiratory infection seeing an uptick in cases.

Click on the links below to jump ahead to a certain fall ailment: Flu COVID-19 Colds RSV Fall allergies Symptoms Sore throat, runny or stuffy nose and cough are all symptoms that the flu (aka ...

Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older, ...

Influenza, RSV and SARS-CoV-2 are still the top three viruses to watch out for in the fall and winter, but several public health tools that have become available in the past year should help boost ...

Free shots that can protect babies from respiratory syncytial virus are being offered by some health-care providers in Ontario and the Northwest Territories. The RSV immunization program designed ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, today announced that the United States National Institutes of Health ...